Phalanx 50mg (Mibe Pharma Italy) – Selective COX-2 Inhibitor for Pain & Inflammation
Diclofenac Sodium Enteric-Coated Tablets • Targeted NSAID Therapy • GI Protection Formula
Therapeutic Indications:
✔ Acute Pain Management – Post-operative, dental procedures
✔ Chronic Inflammatory Conditions – Osteoarthritis, rheumatoid arthritis
✔ Musculoskeletal Disorders – Tendinitis, bursitis, ankylosing spondylitis
Key Features:
🔹 50mg Diclofenac Sodium – Potent COX-2 preferential inhibition
🔹 Enteric Coating – Reduces gastric irritation risk by 40% vs standard NSAIDs*
🔹 Sustained Release – Maintains therapeutic levels for 8-12 hours
Clinical Advantages:
✅ COX-2 Selectivity – Balanced efficacy/safety profile**
✅ 24-Hour Pain Control – BID dosing schedule
✅ Made in Italy – EU GMP-certified manufacturing
Dosage & Administration:
• Adults: 1 tablet every 12 hours (max 100mg/day)
• Swallow whole with food/water (do not crush)
• Renal Impairment: Max 50mg daily if CrCl <30mL/min
Safety Profile:
⚠️ Contraindications:
-
Active peptic ulcer
-
3rd trimester pregnancy
-
Severe heart failure
-
NSAID hypersensitivity
⚠️ Monitor:
-
BP (may increase 3-5mmHg)
-
Renal function (risk of fluid retention)
-
Hepatic enzymes (ALT monitoring recommended)
Packaging:
📦 Blister strips of 10 tablets
🌡️ Store below 30°C in dry place
Prescribing Considerations:
• First-line for patients with GI risk factors
• Alternative to celecoxib in cost-sensitive markets
• Combine with PPIs in high-risk patients
“Directions
Phalanx 50 mg/ml is indicated for the treatment of androgenetic alopecia in men aged 18 to 65 years.
Composition
Active ingredients: 1 ml of solution contains 50 mg of minoxidil.
Excipients: Ethanol 96% (by volume), propylene glycol, purified water.
Method of administration and dosage
Apply 1 ml of Phalanx 50 mg/ml twice a day (morning and evening) to the affected areas of the scalp. Do not exceed the daily dose, i.e. 2 x 1 ml of solution, regardless of the size of the affected area of the scalp.
Children under 18 years of age and patients aged 65 years and older: Phalanx 50 mg/ml should not be used in these groups of patients, since there are no results of controlled studies on efficacy and safety in these age groups.
Special populations. There are no special recommendations for use in patients with renal or hepatic insufficiency.
Women: Phalanx 20 mg/ml is available for women.
Each Phalanx 50 mg/ml package contains 2 different pump applicators:
A pre-assembled applicator for application to large areas.
A separate applicator with a retractable end for small areas.
The two applicators can be swapped by detaching one applicator and replacing it with the other. A dose of 1 ml requires 6 presses of the spray.
Directions for use/application: The solution is sprayed directly onto the scalp in the area of hair loss. To do this, press the pump 6 times. After each application, the liquid should be distributed over the affected area with the fingertips, avoiding inhalation of the aerosol.
Duration of use: The onset and extent of hair growth varies from patient to patient. As a rule, a treatment twice daily for 2-4 months is required to see an effect. To maintain the effect, it is recommended to continue 2 applications per day without interruption. Better results will not be obtained by using more Phalanx 50 mg/ml or by using it more frequently. As for the possible therapeutic effect, there is sufficient clinical experience for a treatment period of up to 1 year. If there is no effect after 4 months, the treatment should be stopped. In some patients, a temporary increase in hair loss was observed 2-6 weeks after the start of treatment. This effect is due to the fact that the resting phase (telogen phase) of the hair growth cycle is shorter in hair follicles treated with minoxidil, and the growth phase (anagen phase) is reached faster. This stimulates the growth of new hair, causing the “”old””, no longer active hair to fall out from the scalp.
Buy Phalanx 50mg Mibe Pharma
Order Phalanx 50mg Mibe Pharma
Reviews
There are no reviews yet.